Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Want to be a successful entrepreneur? try a doctorate

13 February 2014

The recent sale of London tech start-up DeepMind to Google for a reported £400m is the latest in a series of deals highlighting the ever-increasing entrepreneurial spirit of Britain's scientists - and does much to dispel the myth that the UK is good at science but poor at innovation and enterprise.

Read the full article at stephencaddick.blogspot.co.uk